Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 CAD | +62.50% | +85.71% | -7.14% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Christina Wu
DFI | Director of Finance/CFO | - | 20-03-04 |
Peter Pavlin
COO | Chief Operating Officer | - | 22-05-18 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-13 |
Cameron Cole
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Lacey
CHM | Chairman | 67 | 20-03-10 |
Ronnie Hershmann
BRD | Director/Board Member | - | 20-02-08 |
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Loran Swanberg
BRD | Director/Board Member | - | 20-04-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 87,122,318 | 76,495,316 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 2.55M | |
+14.93% | 118B | |
+12.99% | 106B | |
-3.68% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.92% | 15.56B | |
+5.32% | 13.63B | |
+28.76% | 12.27B |
- Stock Market
- Equities
- HEM Stock
- Company Hemostemix Inc.